Project Grant K23HL186119
Award Date 8/15/26
Completion Date 7/31/31
Dollars Obligated $187K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, ME 04102, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $353,776 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 20, 2025. The award funds investigation of place-based factors contributing to sleep health disparities in the United States. The research links nationwide public health surveillance data to neighborhood-level factors using geographic information science to test whether individual-level and place-based factors...
- The National Heart Lung and Blood Institute awarded Brigham & Women's Hospital $3.243748 million on September 23, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of ambient lighting in circadian misalignment within a chronic variable sleep deficiency paradigm and its impacts on sleep, cognition, and central oxidative stress. The research examines how irregular sleep schedules—common among U.S. adults accommodating social and work...
- The National Heart, Lung, and Blood Institute awarded The General Hospital Corporation, doing business as Massachusetts General Hospital, $169,348 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research applying partitioned polygenic risk scoring and machine learning-derived imaging phenotypes to discover novel mechanisms of cardiometabolic disease in people of South Asian ancestry. Dr. Bhattacharya will develop unbiased SNP-level and gene...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $117,000 on July 7, 2026, for a proof-of-concept study examining aerobic exercise as a countermeasure to cardiometabolic impairments caused by circadian misalignment in night shift workers, funded under the Cardiovascular Diseases Research program (CFDA 93.837). The research will employ a randomized crossover study with a six-day simulated shiftwork...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $492,250 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct data-driven phenotyping of obstructive sleep apnea and sex-specific cardiovascular consequences. The research integrates high-dimensional physiological and clinical data from the Mass General Brigham Health System electronic health record cohort, which includes over 144,000 patients with structured records...
- The National Institutes of Health National Heart Lung and Blood Institute awarded the University of Pittsburgh $190,168 on July 2, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support Dr. Malamo Countouris's research into reversing left ventricular remodeling in women with a history of preeclampsia and current hypertension. The award funds Dr. Countouris's career development as an independent physician-scientist and clinical trial leader in cardio-obstetrics. The...
- The National Heart, Lung, and Blood Institute awarded Emory University $100,228 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research examining associations between sleep health, protective factors against psychosocial adversity, and stress-related biomarkers including allostatic load and epigenetic age acceleration. The project analyzes multidimensional sleep health—encompassing regularity, satisfaction, alertness, timing,...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded the Massachusetts General Hospital's Research Management Division $842,536 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the mechanisms linking gestational diabetes mellitus (GDM) to increased coronary artery disease risk in women. The research integrates longitudinal electronic health records data spanning approximately 30 years postpartum for more than 208,000 women with GDM...
- The National Heart, Lung, and Blood Institute awarded New York University's Long Island School of Medicine $201,744 on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support Dr. Arabadjian's progression from mentored researcher to independent investigator focused on cardiovascular health promotion among socially vulnerable mothers of young children. The award funds a career development program combining structured training in clinical trial design,...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded Boston Children's Hospital $171,600 on September 1, 2026, under CFDA 93.837 (Cardiovascular Diseases Research) to support career development and mentored research in pediatric obstructive sleep apnea diagnostics. The award funds the recipient investigator's training in three areas: predictive modeling and machine learning, advanced physiological signal analysis, and implementation science for translating research into clinical...